Skip to main content
Premium Trial:

Request an Annual Quote

Hybrigenics Acquires Dualsystems Biotech's Yeast Two-Hybrid Business

NEW YORK (GenomeWeb News) – Hybrigenics has acquired the yeast two-hybrid assets of Swiss biotech firm Dualsystems Biotech.

The acquisition provides Hybrigenic Services, a subsidiary of Paris-based biopharma firm Hybrigenics that specializes in protein-protein interaction work, with exclusive ownership of patented yeast two-hybrid screening technology for membrane proteins. The deal will expand the company's commercial reach in German-speaking territories, Eastern Europe, and China, it said.

Dualsystems Biotech's yeast two-hybrid operation "is both a business and technology opportunity which fits precisely well with our current expert leadership position in the field of functional proteomics," Hybrigenics CEO Remi Delansorne said in a statement.

Financial terms of the deal were not disclosed. Hybrigenics noted, however, that it would not involve the issuance of any of its shares.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.